Meeting
2023 ASCO Genitourinary Cancers Symposium
Results of a multicenter, randomized, phase 3 trial of trimodality therapy with I-125 brachytherapy, external beam radiation therapy, and long- versus short-term androgen deprivation therapy for localized high-risk prostate cancer (TRIP/TRIGU0907).
Presenter
Atsunori Yorozu, MD, PhD
National Hospital Organization Tokyo Medical Center
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Videos & Slides Details
Session Type
Rapid Oral Abstract Session
Session Title
Rapid Abstract Session: Prostate Cancer
Track
Prostate Cancer - Advanced,Prostate Cancer - Localized
Sub Track
Therapeutics
Clinical Trial Registration Number
UMIN000003992
Citation
J Clin Oncol 41, 2023 (suppl 6; abstr 305)
DOI
10.1200/JCO.2023.41.6_suppl.305
Abstract #
305
Abstract Disclosures
Similar Videos & Slides
Videos & Slides
2023 ASCO Genitourinary Cancers Symposium
Results of a multicenter, randomized, phase 3 trial of trimodality therapy with I-125 brachytherapy, external beam radiation therapy, and long- versus short-term androgen deprivation therapy for localized high-risk prostate cancer (TRIP/TRIGU0907).
Speaker: Atsunori Yorozu, MD, PhD
Speaker: Panel Discussion
Videos & Slides
2021 Genitourinary Cancers Symposium
Timing of high-dose rate brachytherapy with external beam radiotherapy in intermediate and high-risk localized prostate cancer (THEPCA) patients and its effects on toxicity and quality of life: Results of a randomized feasibility trial.
Speaker: Imtiaz Ahmed
Videos & Slides
2019 Genitourinary Cancers Symposium
PACE: Analysis of acute toxicity in PACE-B, an international phase III randomized controlled trial comparing stereotactic body radiotherapy (SBRT) to conventionally fractionated or moderately hypofractionated external beam radiotherapy (CFMHRT) for localized prostate cancer (LPCa).
Speaker: Nicholas John Van As, MBBCH, MRCP, FRCR, MD(res)